DarioHealth Corp.

NASDAQ:DRIO

Medical - Diagnostics & Research

Healthcare
$5.13 -1.68%

-$0.12 today

Market cap
$50.27M
Beta
1.08
P/E (TTM)
5.5
EPS (TTM)
$1.26
52W Low $5.94High $17.74

Volume 0.01M

Average 0.01M

DRIO Net Debt

Total debt minus cash and equivalents; a negative value means the company holds more cash than debt.

DarioHealth Corp.NASDAQ: DRIO

Net Debt · Q1 FY2026 · quarter ended Mar 2026

Net debt rises 365.2% from a year ago

Net debt stood at $11.55M at the end of Q1 FY2026, up 365.2% from a year earlier and up 110.0% from the prior quarter.

Context

  • Net debt amounted to 11.2% of total assets at the end of Q1 FY2026, up 9.0 pp from a year earlier.
  • Net debt increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether net debt keeps rising in the next quarterly balance sheet after a +365.2% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$11.55M+110.0% QoQ
Last fiscal yearDec 2025
$5.5M+126.6% YoY
Year agoMar 2025
$2.48M+365.2% since
Net Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+365.2%——
1 year+126.6%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Net Debt history

USD · from the balance sheet

Latest · FY2025
5.5M USD
Year-over-year change
+126.6%

Net Debt vs competitors

How DRIO compares with its peers on the latest reported figures

  • DRIO's Mar 2026 net debt of $11.55M is the 6th highest of the 11 companies compared; the peer median is $27.07M.
  • Its year-over-year change of +365.2% is the highest of 11, against a peer median of +33.2%.
  • Net debt amounts to 11.2% of total assets for DRIO, versus a peer median of 12.9%.
DRIO Competitors Peer median
Net Debt for DRIO and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
PACBPacific Biosciences of California, Inc.Mar 2026$647.1M +1.0%+3.7%82.7%
OFIXOrthofix Medical Inc.Mar 2026$114.11M -15.4%—12.9%
MYGNMyriad Genetics, Inc.Mar 2026$87.1M +32.4%-11.9%12.9%
AVNSAvanos Medical, Inc.Mar 2026$72.8M +65.8%-35.9%6.9%
RGNXREGENXBIO Inc.Mar 2026$55.84M +211.1%—16.3%
DRIODarioHealth Corp.Mar 2026$11.55M +365.2%—11.2%
INNVInnovAge Holding Corp.Mar 2026-$1.7M -103.8%—0.3%
ABSIAbsci CorporationMar 2026-$4.21M +88.9%—2.2%
NNNNAnbio Biotechnology Class A Ordinary SharesDec 2025-$7.77M +34.0%—25.7%
FLGTFulgent Genetics, Inc.Mar 2026-$13.23M +77.8%—1.1%
VSTMVerastem, Inc.Mar 2026-$80.08M -96.4%—35.2%
Peer median (excluding DRIO) $27.07M+33.2%-11.9%12.9%

Competitors are the stored peer set for DRIO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents36M49.36M36.8M27.76M26.25M
Short-term Investments000697K0
Net Receivables1.79M6.42M3.64M5.35M2.67M
Inventory6.23M7.96M5.06M4.75M4.32M
Other Current Assets0887K292K175K0
Total Current Assets45.61M65.52M47.33M40.53M34.81M
Property, Plant & Equipment (Net)989K1.99M1.87M1.77M1.27M
Goodwill41.64M41.64M41.64M57.43M57.43M
Intangible Assets12.46M9.92M5.4M18.76M15.93M
Long-term Investments20K6K6K080K
Tax Assets0(6K)000
Other Non-current Assets57K117K143K392K562K
Total Non-current Assets55.17M53.67M49.06M78.36M75.27M
Total Assets100.77M119.19M96.39M118.88M110.08M
Account Payables5.11M2.32M1.13M3.05M2.93M
Short-term Debt266K8.82M3.95M5.45M430K
Tax Payables00000
Deferred Revenue1.2M1.32M997K1.58M714K
Other Current Liabilities4.4M2.19M4.07M4.11M5.25M
Total Current Liabilities14.38M19.35M12.49M16.64M9.32M
Long-term Debt018.11M24.59M23.47M30.75M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities825K910K276K5.99M1.51M
Total Non-current Liabilities846K19.84M25.75M30.23M32.83M
Total Liabilities15.22M39.19M38.25M46.87M42.15M
Common Stock2K3K3K4K4K
Retained Earnings(222.01M)(285.85M)(349.36M)(390.34M)(452.08M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity85.55M80M58.14M72.02M67.92M
Total Debt287K28.05M29.54M30.19M31.75M
Net Debt(35.71M)(21.31M)(7.26M)2.43M5.5M

DarioHealth Corp.

NASDAQ:DRIO

Intrinsic Alpha fair value

Locked

Current Price

$5.13

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.